For qualified clinicians only. Country protocol recommendations reflect current national malaria treatment guidelines but may differ from individual facility or programme guidance. Always verify against your national treatment guidelines and patient-specific factors. Report any dosing discrepancy using the flag link below.
Select Country / Protocol
🇳🇬
Nigeria
AL 1st line
🇰🇪
Kenya
AL 1st line
🇬🇭
Ghana
AL 1st line
🇺🇬
Uganda
AL 1st line
🇹🇿
Tanzania
AL 1st line
🇮🇳
India
AL / DHA-PQP
Clinically reviewed by
Dr. Aminu Bello, FMCP
Consultant Physician & Infectious Disease Specialist, Nigeria
Updated
2025-11-01
2025-11-01
Patient Parameters
kg
yrs
Select ACT Regimen
Artemether-Lumefantrine
Coartem® / Lonart® / Lumartem®
1st Line (Most Countries)
DHA-Piperaquine
Eurartesim® / DHA-PQP
1st/2nd Line (India, Tanzania)
Artesunate-Mefloquine
AS-MQ / ASAQ alternative
2nd Line
Artesunate-Amodiaquine
ASAQ / Coarsucam®
Alt (Ghana, West Africa)
ACT Dosing Result
Single Dose (Per Administration)
— mg
Frequency
—
Duration
—
Total Doses
—
Dosing Schedule
Sources: WHO Malaria Treatment Guidelines 2022 ·
Nigeria NMEP ACT Guidelines 2020 · Kenya NMCP Treatment Guidelines 2021 · Ghana GHS Malaria Guidelines · Uganda NMCP ACT Protocol 2020 · NVBDCP India ACT Guidelines
| 🚩 Flag a dosing concern
AL Weight-Band Quick Reference
Nigeria / Kenya / Ghana / Uganda| Weight (kg) | Age (approx.) | Tablets/dose | Total tabs (course) | Protocol note |
|---|